A detailed history of Private Advisor Group, LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Private Advisor Group, LLC holds 93,063 shares of NVO stock, worth $10.1 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
93,063
Previous 94,137 1.14%
Holding current value
$10.1 Million
Previous $13.4 Million 17.53%
% of portfolio
0.07%
Previous 0.09%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$119.07 - $145.42 $127,881 - $156,181
-1,074 Reduced 1.14%
93,063 $11.1 Million
Q2 2024

Aug 05, 2024

SELL
$122.71 - $146.91 $109,702 - $131,337
-894 Reduced 0.94%
94,137 $13.4 Million
Q1 2024

Apr 30, 2024

SELL
$102.11 - $135.92 $14,908 - $19,844
-146 Reduced 0.15%
95,031 $12.2 Million
Q4 2023

Feb 06, 2024

BUY
$87.78 - $105.45 $204,966 - $246,225
2,335 Added 2.52%
95,177 $9.85 Million
Q3 2023

Nov 02, 2023

BUY
$90.94 - $199.54 $4.38 Million - $9.62 Million
48,216 Added 108.04%
92,842 $8.44 Million
Q2 2023

Aug 09, 2023

BUY
$155.98 - $172.65 $69,255 - $76,656
444 Added 1.0%
44,626 $7.22 Million
Q1 2023

May 10, 2023

BUY
$132.34 - $159.14 $301,602 - $362,680
2,279 Added 5.44%
44,182 $7.03 Million
Q4 2022

Jan 18, 2023

BUY
$102.55 - $135.33 $127,469 - $168,215
1,243 Added 3.06%
41,903 $0
Q3 2022

Oct 14, 2022

SELL
$95.28 - $116.93 $2.16 Million - $2.65 Million
-22,699 Reduced 35.83%
40,660 $4.05 Million
Q2 2022

Jul 13, 2022

BUY
$103.24 - $121.81 $409,036 - $482,611
3,962 Added 6.67%
63,359 $7.06 Million
Q1 2022

May 12, 2022

BUY
$93.1 - $112.54 $117,864 - $142,475
1,266 Added 2.18%
59,397 $6.6 Million
Q4 2021

Feb 10, 2022

SELL
$95.88 - $117.08 $3.58 Million - $4.38 Million
-37,379 Reduced 39.14%
58,131 $6.51 Million
Q3 2021

Oct 14, 2021

BUY
$84.42 - $106.62 $3.54 Million - $4.48 Million
41,991 Added 78.46%
95,510 $9.17 Million
Q2 2021

Aug 12, 2021

BUY
$67.66 - $84.76 $195,808 - $245,295
2,894 Added 5.72%
53,519 $4.48 Million
Q1 2021

Apr 22, 2021

BUY
$67.06 - $75.82 $550,964 - $622,937
8,216 Added 19.37%
50,625 $3.41 Million
Q4 2020

Apr 01, 2021

BUY
$63.89 - $73.8 $377,462 - $436,010
5,908 Added 16.19%
42,409 $2.96 Million
Q3 2020

Nov 02, 2020

BUY
$63.69 - $70.22 $149,480 - $164,806
2,347 Added 6.87%
36,501 $2.44 Million
Q2 2020

Aug 17, 2020

SELL
$58.54 - $67.94 $302,066 - $350,570
-5,160 Reduced 13.13%
34,154 $2.24 Million
Q1 2020

May 12, 2020

BUY
$49.46 - $64.78 $101,491 - $132,928
2,052 Added 5.51%
39,314 $2.37 Million
Q4 2019

Feb 10, 2020

BUY
$49.86 - $58.26 $20,642 - $24,119
414 Added 1.12%
37,262 $2.16 Million
Q3 2019

Nov 13, 2019

BUY
$47.54 - $53.43 $285,715 - $321,114
6,010 Added 19.49%
36,848 $1.99 Million
Q2 2019

Aug 14, 2019

BUY
$46.79 - $52.47 $800,155 - $897,289
17,101 Added 124.49%
30,838 $1.57 Million
Q1 2019

May 13, 2019

SELL
$46.36 - $52.63 $1.09 Million - $1.24 Million
-23,505 Reduced 63.11%
13,737 $709,000
Q4 2018

Feb 11, 2019

BUY
$41.54 - $47.25 $988,652 - $1.12 Million
23,800 Added 177.06%
37,242 $1.72 Million
Q3 2018

Nov 01, 2018

SELL
$46.76 - $51.24 $1.01 Million - $1.1 Million
-21,527 Reduced 61.56%
13,442 $634,000
Q2 2018

Aug 09, 2018

BUY
$44.29 - $50.42 $1.3 Million - $1.48 Million
29,297 Added 516.52%
34,969 $1.62 Million
Q1 2018

May 09, 2018

SELL
$48.49 - $58.14 $208,507 - $250,002
-4,300 Reduced 43.12%
5,672 $279,000
Q4 2017

Feb 07, 2018

SELL
$47.53 - $53.73 $189,502 - $214,221
-3,987 Reduced 28.56%
9,972 $541,000
Q3 2017

Nov 13, 2017

BUY
$41.15 - $49.22 $95,879 - $114,682
2,330 Added 20.04%
13,959 $683,000
Q2 2017

Aug 10, 2017

BUY
N/A
11,629
11,629 $491,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $244B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Private Advisor Group, LLC Portfolio

Follow Private Advisor Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Advisor Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Advisor Group, LLC with notifications on news.